Literature DB >> 25915006

Toxicology Studies for Inhaled and Nasal Delivery.

R K Wolff1.   

Abstract

This review examines issues related to the toxicological testing of pharmaceuticals delivered by the inhalation or nasal route. The purpose of the toxicology studies is to conduct studies in animals that will aid the assessment of the safety of these agents delivered to patients. Inhalation toxicology studies present some unique issues because the dosing method differs from more standard administration methods such as oral or injection administration. Also, dose determination issues are more complex, particularly for inhalation administration since it is often difficult to determine the amount of material delivered to the lung both for patients and in animal toxicology studies.

Entities:  

Keywords:  MMAD; aerosols; excipients; inhalation toxicology; inhaled pharmaceutical; lung; nasal; pulmonary; respiratory tract toxicity

Mesh:

Substances:

Year:  2015        PMID: 25915006     DOI: 10.1021/acs.molpharmaceut.5b00146

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.

Authors:  Nicholas B Carrigy; Sasha E Larsen; Valerie Reese; Tiffany Pecor; Melissa Harrison; Philip J Kuehl; Graham F Hatfull; Dominic Sauvageau; Susan L Baldwin; Warren H Finlay; Rhea N Coler; Reinhard Vehring
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

2.  Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System.

Authors:  Jonathan E Phillips; Xuxia Zhang; James A Johnston
Journal:  J Vis Exp       Date:  2017-04-06       Impact factor: 1.355

3.  Intranasal MMI-0100 Attenuates Aβ1-42- and LPS-Induced Neuroinflammation and Memory Impairments via the MK2 Signaling Pathway.

Authors:  JinHong Jiang; Zhe Wang; XueYa Liang; YaoYan Nie; Xin Chang; HongXiang Xue; Shu Li; Chang Min
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

4.  The Fate of Intranasally Instilled Silver Nanoarchitectures.

Authors:  Agata Zamborlin; Maria Laura Ermini; Maria Summa; Giulia Giannone; Valentina Frusca; Ana Katrina Mapanao; Doriana Debellis; Rosalia Bertorelli; Valerio Voliani
Journal:  Nano Lett       Date:  2022-06-30       Impact factor: 12.262

5.  A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation.

Authors:  Prakash Khadka; Jack Dummer; Philip C Hill; Rajesh Katare; Shyamal C Das
Journal:  Drug Deliv Transl Res       Date:  2022-09-21       Impact factor: 5.671

6.  Biokinetics and clearance of inhaled gold ultrasmall-in-nano architectures.

Authors:  Ana Katrina Mapanao; Giulia Giannone; Maria Summa; Maria Laura Ermini; Agata Zamborlin; Melissa Santi; Domenico Cassano; Rosalia Bertorelli; Valerio Voliani
Journal:  Nanoscale Adv       Date:  2020-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.